GLP-1 Households Cut Grocery Spending 3.8%. Walmart Built A Page For Where It Went.

A current GLP-1 user now lives in 22% of U.S. households, double the share recorded in October 2023, according to the latest wave of Numerator’s quarterly GLP-1 usage tracker, which the firm says drew on more than 95,000 survey responses. Numerator separately reported that those households spent 3.8% less at grocery than comparable non-using households after one year, and that GLP-1 users now account for more than $660 billion in spending across CPG, general merchandise, and quick-service restaurants.

Numerator also reported a threshold crossing most coverage left out. For the first time, use exclusively for weight loss exceeds use for diabetes. The firm told FoodNavigator that 11.1% of U.S. households now use the medications exclusively for weight loss, against 9.7% using them for diabetes management or a combination of the two.

Gallup measured the expansion on a different basis and found the same direction. Current use of GLP-1 medications for weight loss among U.S. adults reached 11% in 2026, up from 8% in 2025 and 3% in 2024, in a probability-based survey of 5,065 adults conducted from late May into early June. Awareness now stands at 91%. Gallup counts individual adults taking the medications for weight loss, while Numerator counts households containing any current user, so the two figures are not interchangeable.

Walmart’s exposure to whatever this population does is larger than anyone else’s. Its grocery penetration reached a record 72% in Wave 12 of the dunnhumby Consumer Trends Tracker released in February, a six percentage point year-over-year gain and the largest increase among all retailers dunnhumby measured. The retailer serves more than 190 million Americans monthly.

The Variance Inside The Number Is The Story

The 3.8% figure measures the whole grocery basket. Underneath a decline that size, individual categories are not moving together, and that variance determines whether a given supplier faces a headwind or a tailwind.

Numerator found GLP-1 baskets moving away from pantry staples and carb-centric items including pasta and bakery goods, and toward fresh protein, seafood, functional nutrition, and what the firm calls more intentional snacking. That is a migration from center store to perimeter. A supplier reading only the total will conclude something very different from a supplier reading the composition.

Cornell researchers reached the same conclusion working from the same underlying data. Their study, published in the Journal of Marketing Research in December, used Numerator’s transaction panel matched to repeated surveys on adoption and timing, allowing comparison against similar non-adopting households. The sharpest declines landed in calorie-dense categories, with savory snacks down roughly 10% and comparable decreases in sweets, baked goods, and cookies. That is independent analysis rather than independent measurement, and it is worth weighing on those terms, but the researchers had no stake in the outcome.

The Money Left Food. It Did Not Leave The Store.

Numerator reported that among users who began treatment in 2025, cumulative spending six months after starting ran 33% higher on fragrance, 21% higher on immunity supplements, and 14% higher on skincare than comparable households. That comparison covers a different cohort and a shorter window than the one-year grocery figure, and the two should not be read as offsetting each other. What the figures describe is a household moving discretionary dollars toward appearance and self-care while trimming food.

Walmart has been reporting strength in those aisles. On the first quarter fiscal 2027 earnings call in May, Executive Vice President and Chief Financial Officer John David Rainey identified beauty as a standout category and said roughly 75% of its growth came from new brands. He also said merchandise category mix contributed favorably to Walmart U.S. gross margin for the first time in 18 quarters, driven by general merchandise. Walmart U.S. gross profit grew 29 basis points in the quarter, with contributions from business mix and merchandise mix partly offset by higher fuel costs.

Numerator did not measure Walmart, and Walmart did not attribute beauty growth to GLP-1 households. The implication suppliers should weigh is that a shopper trading food dollars for self-care dollars is a favorable mix shift for a retailer selling both, and an unfavorable one for a supplier selling only the first.

Walmart Redesigned The Destination In April

Five weeks before that earnings call, Walmart announced from Bentonville that it was expanding its Better Care Services platform, launched in January, with weight management offerings for customers on or exploring GLP-1 therapies.

The April 16 release describes access to a portfolio of GLP-1 medications across nearly 4,600 pharmacies, including newly available oral options such as orforglipron, sold through insurance or transparent cash-pay pricing, with same-day delivery available in as fast as an hour in many locations. The platform connects customers to five third-party providers: Aaptiv, Berry Street, Curai Health, MyCare by Twin Health, and Wheel. Kevin Host, Senior Vice President of Pharmacy for Walmart U.S., framed the expansion around the observation that “access to medication is only one part of the equation.”

Two elements bear directly on merchandising. Walmart said it was launching a redesigned GLP-1 digital destination on Walmart.com to help customers explore related products and services. It also connected the platform to Nutrition Hub, powered by Walmart Everyday Health Signals, which the company describes as guiding personalized food and recipe choices.

Both are discovery surfaces, and a curated discovery surface is a shelf. Walmart has now told the market it is steering GLP-1 customers toward related products and toward guided food and recipe choices. What that means for any individual category is a question for a supplier’s own merchant conversation, and it is a more concrete question than anything the spending data alone raises.

The release also noted that beginning in July, eligible Medicare Part D beneficiaries gain access to certain GLP-1 medications through a short-term CMS demonstration called the Medicare GLP-1 Bridge.

Churn Is The Reason To Discount Long-Range Forecasts Built On This

The finding most likely to be underweighted sits at the end of Numerator’s data. Nearly two-thirds of former users discontinue treatment within six months. Another 23% of U.S. consumers say they would consider starting.

Numerator’s own read is that the market remains largely shaped by recent adopters. That is a real caution on any multi-year category forecast built from current behavior, because the population generating the data turns over quickly and this tracker does not establish how durable the habits are after discontinuation. A supplier restructuring a portfolio around permanent demand destruction in center store is making a bet this research does not underwrite.

1P And 3P Face Opposite Versions Of This

For 1P suppliers, this is a category event before it is a segment event. A pasta or sweet bakery supplier and a fresh protein or seafood supplier read the same research to opposite conclusions. The practical consequence sits in forecast assumptions and line review positioning. A center-store supplier arriving with volume softness and no explanation is weaker than one who names the behavioral driver, sizes it honestly at 3.8% rather than inflating it, and shows work on the receiving side of the shift. Protein, fiber, and functional nutrition positioning is where Numerator says the basket is going.

For 3P Marketplace sellers, the self-care figures are the ones to read. Fragrance, skincare, and supplements are long-tail categories where Marketplace assortment runs deep and where emerging brands compete without a physical planogram’s constraints. Rainey’s observation that roughly three-quarters of Walmart’s beauty growth came from new brands describes a category actively absorbing entrants. A seller in supplements or skincare is looking at a documented demand signal, a receptive retailer, and no fixture limit.

Walmart reports second quarter fiscal 2027 results on August 20, covering the quarter in which the Medicare demonstration began. The destination redesign landed in the quarter before it. Numerator’s next wave follows. The number worth watching is not whether grocery spending falls again, which it likely will, but whether the categories gaining share hold those gains as the adopter population turns over beneath them.

Winning With Walmart

Winning With Walmart is an independent platform for suppliers, sellers, solution providers, and industry experts.

Articles are developed by staff editors, contributing experts, and trusted partners.

Some are researched and drafted with the assistance of AI tools and are reviewed, fact-checked, and edited by Winning With Walmart editors before publication.

Editorial judgment, sourcing decisions, and final approval rest with the publication's human editors in every case.

We are committed to accuracy and fairness. If you believe this article contains an error, we welcome your feedback.